Terms: = Prostate cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
10 results:
1. RILP inhibits proliferation, migration, and invasion of PC3 prostate cancer cells.
Wang Z; Zhou Y; Nie D; Tan Y; Zhao S; Wang G; Wang T
Acta Histochem; 2022 Oct; 124(7):151938. PubMed ID: 35981451
[TBL] [Abstract] [Full Text] [Related]
2. Rectal preparation significantly improves prostate imaging quality: Assessment of the PI-QUAL score with visual grading characteristics.
Arnoldner MA; Polanec SH; Lazar M; Noori Khadjavi S; Clauser P; Pötsch N; Schwarz-Nemec U; Korn S; Hübner N; Shariat SF; Helbich TH; Baltzer PAT
Eur J Radiol; 2022 Feb; 147():110145. PubMed ID: 35007983
[TBL] [Abstract] [Full Text] [Related]
3. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent ralgefs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology.
Shan Y; Chen X; Liu K; Zeng M; Zhou J
Abdom Radiol (NY); 2019 Oct; 44(10):3441-3452. PubMed ID: 31144091
[TBL] [Abstract] [Full Text] [Related]
5. RILP suppresses invasion of breast cancer cells by modulating the activity of RalA through interaction with ralgds.
Wang Z; Zhou Y; Hu X; Chen W; Lin X; Sun L; Xu X; Hong W; Wang T
Cell Death Dis; 2015 Oct; 6(10):e1923. PubMed ID: 26469971
[TBL] [Abstract] [Full Text] [Related]
6. A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of prostate cancer: An Update.
Chen Y; Zhong H; Gao JG; Tang JE; Wang R
Urol J; 2015 Jul; 12(3):2138-47. PubMed ID: 26135929
[TBL] [Abstract] [Full Text] [Related]
7. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
Adibi M; Pearle MS; Lotan Y
BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
[TBL] [Abstract] [Full Text] [Related]
8. Activation of the ralgef/Ral pathway promotes prostate cancer metastasis to bone.
Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
[TBL] [Abstract] [Full Text] [Related]
9. Choline kinase: an important target for cancer.
Janardhan S; Srivani P; Sastry GN
Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
[TBL] [Abstract] [Full Text] [Related]
10. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
[TBL] [Abstract] [Full Text] [Related]
